Clinical Trials Browser

Phase 1 × Unknown × pyrotinib × Clear all

NCT02500199 2021-02-01

Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors

Phase 1 Unknown

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT02378389 2015-03-04

Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer

Phase 1 Unknown

Gastrointestinal

HER2 Positive Gastric Cancer